Cedric Francois Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Cedric Francois is Chief Executive Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 331,605 shares of APLS, which is worth approximately $8.24 Million. The most recent transaction as insider was on Feb 10, 2021, when has been sold 2,523 shares (Common Stock) at a price of $47.72 per share, resulting in proceeds of $120,398. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 332K

20.23% 3M change

5.72% 12M change

Total Value Held $8.24 Million

Cedric Francois Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2021	SELL Payment of exercise price or tax liability	$120,398 $47.72 p/Share	2,523 Reduced 0.21%	1,219,833 Common Stock
Jan 28 2021	BUY Grant, award, or other acquisition	-	37,500 Added 2.98%	1,222,356 Common Stock
Jan 27 2021	BUY Exercise of conversion of derivative security	$289,979 $4.04 p/Share	71,777 Added 5.71%	1,184,856 Common Stock
Dec 15 2020	SELL Open market or private sale	$260,800 $52.16 p/Share	5,000 Reduced 0.45%	1,113,079 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$150,400 $3.76 p/Share	40,000 Added 3.45%	1,118,079 Common Stock
Nov 16 2020	SELL Open market or private sale	$196,900 $39.38 p/Share	5,000 Reduced 0.46%	1,078,079 Common Stock
Oct 15 2020	SELL Open market or private sale	$172,300 $34.46 p/Share	5,000 Reduced 0.46%	1,083,079 Common Stock

Cedric Francois

Chief Executive Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account